Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: AF Suppression Trial

Trial Profile

Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: AF Suppression Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Irbesartan (Primary) ; Amlodipine
  • Indications Atrial fibrillation; Hypertension
  • Focus Therapeutic Use
  • Acronyms SILK
  • Most Recent Events

    • 10 Jun 2016 Status changed from recruiting to completed.
    • 19 Aug 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 17 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top